Selective Metabotropic Glutamate Receptor 5 (mGlu5) Antagonism Reduces L-DOPA-Induced Dyskinesia in MPTP-Lesioned Primates at the Expense of Anti-Parkinsonian Benefit

被引：0
|
作者：
Johnston, Tom H.
Fox, Susan H.
Piggott, Matthew J.
Brotchie, Jonathan M.
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [41] ADX48621, an MGluR5 negative allosteric modulator alleviates L-DOPA-induced chorea and dystonia in the MPTP-lesioned macaque model of Parkinson's disease
    Keywood, C.
    Hill, M.
    Girard, F.
    Bezard, E.
    Poli, S.
    Mutel, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 96 - 96
  • [42] 5-HT4R agonism reduces L-DOPA-induced dyskinesia via striatopallidal neurons in unilaterally 6-OHDA lesioned mice
    Ballardin, Demetra
    Makrini-Maleville, Leila
    Seper, Alexander
    Valjent, Emmanuel
    Rebholz, Heike
    NEUROBIOLOGY OF DISEASE, 2024, 198
  • [43] Ondansetron, a highly-selective 5-HT3 receptor antagonist, alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Kwan, C.
    Frouni, I.
    Bedard, D.
    Hamadjida, A.
    Huot, P.
    MOVEMENT DISORDERS, 2018, 33 : S161 - S162
  • [44] Metabotropic glutamate receptor type 5 (mGluR5) antagonists improve L-DOPA-induced-dyskinesia in both rat and macaque models of Parkinson's disease
    Rylander, D.
    Li, Q.
    Dekundy, A.
    Li, H.
    Baishen, R.
    Danysz, W.
    Bezard, E.
    Cenci, A.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S132 - S132
  • [45] AFQ056 a Selective, Non-Competitive mGlu5 Receptor Antagonist in Clinical Development for Fragile X Syndrome and L-Dopa Induced Dyskinesia in PD. Identification and Preclinical Characterization
    Gasparini, F.
    Ofner, S.
    Flor, P. J.
    Bilbe, G.
    McAllister, K.
    Kuhn, R.
    Vranesic, I.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 22 - 23
  • [46] The highly selective 5-HT2A receptor antagonist EMD-281,014 alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Frouni, I.
    Bedard, D.
    Belliveau, S.
    Bourgeois-Cayer, E.
    Hamadjida, A.
    Huot, P.
    MOVEMENT DISORDERS, 2018, 33 : S174 - S174
  • [47] The highly selective mGlu2 receptor positive allosteric modulator LY-487,379 alleviates l-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Hamadjida, Adjia
    Sid-Otmane, Lamia
    Kwan, Cynthia
    Frouni, Imane
    Nafade, Vaidehi
    Bedard, Dominique
    Gagnon, Dave
    Wallman, Marie-Josee
    Rouillard, Claude
    Parent, Andre
    Parent, Martin
    Huot, Philippe
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2020, 51 (12) : 2412 - 2422
  • [48] The selective D3 receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats
    Mela, Flora
    Millan, Mark J.
    Brocco, Mauricette
    Morari, Michele
    NEUROPHARMACOLOGY, 2010, 58 (02) : 528 - 536
  • [49] Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
    Johnston, Tom H.
    Fox, Susan H.
    McIldowie, Matthew J.
    Piggott, Matthew J.
    Brotchie, Jonathan M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (03): : 865 - 873
  • [50] Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat
    Frouni, Imane
    Kwan, Cynthia
    Bedard, Dominique
    Belliveau, Sebastien
    Bourgeois-Cayer, Elodie
    Gaudette, Fleur
    Beaudry, Francis
    Hamadjida, Adjia
    Huot, Philippe
    EXPERIMENTAL BRAIN RESEARCH, 2019, 237 (01) : 29 - 36
12345